Form 8-K - Current report:
SEC Accession No. 0001213900-25-062337
Filing Date
2025-07-09
Accepted
2025-07-09 16:01:48
Documents
14
Period of Report
2025-07-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0248389-8k_longeveron.htm   iXBRL 8-K 26499
2 PRESS RELEASE ISSUED BY THE COMPANY ON JULY 8, 2025 ea024838901ex99-1_longeveron.htm EX-99.1 19210
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9137
  Complete submission text file 0001213900-25-062337.txt   232252

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20250708.xsd EX-101.SCH 3020
5 XBRL LABEL FILE lgvn-20250708_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE lgvn-20250708_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0248389-8k_longeveron_htm.xml XML 3796
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 251113597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)